Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Aurobindo Pharma received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation
Aerosol, 40 mcg and 80 mcg, a generic equivalent of QVAR Inhalation Aerosol 40 mcg and 80 mcg, marketed by Teva Branded Pharmaceutical Products R&D LLC.
At 2.36 pm, Aurobindo Pharma was trading at Rs. 1,658, down by 1.04%, with a volume of 7094 shares on the BSE.
Around 1.69% equity changed hands in the deal
16 Sep 2026, 11:08AMACME Solar commissions 66.68 MW solar capacity & 300 MWh BESS capacity in Rajasthan
16 Sep 2026, 9:52AML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
